Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder

Clinical trial NCT07099534 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07099534
Sponsor: University Hospital, Toulouse
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Infusion of Ketamine in Severe Borderline Personality Disorder Borderline Personality Disorder (BPD)

Start date: 2026-09-01
Primary completion: 2028-09-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.